Evidence map›Paper›PMID 26051842›Full record

ArticleMolecular cancer2015

Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.

Gauri Shishodia, Shirish Shukla, Yogesh Srivastava, Shashank Masaldan, Sumita Mehta, Suresh Bhambhani, Shashi Sharma, Ravi Mehrotra, Bhudev Chandra Das, Alok Chandra Bharti

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gauri ShishodiaDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. gaurishishodia@gmail.com.
Shirish ShuklaDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. shirishshukla31@gmail.com.
Yogesh SrivastavaDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. yansh111@gmail.com.
Shashank MasaldanDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. masaldan@gmail.com.
Sumita MehtaDepartment of Obstetrics and Gynecology, University College of Medical Sciences and Associated Guru Teg Bahadur Hospital, Shahdara, Delhi, New Delhi, India. sumitadr@gmail.com.
Suresh BhambhaniDivision of Cytopathology, Institute of Cytology and Preventive Oncology, I - 7, Sector - 39, Noida, 201301, Uttar Pradesh, India. sureshib@yahoo.com.
Shashi SharmaDivision of Epidemiology and Biostatistics, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. datta582002@yahoo.co.in.
Ravi MehrotraDivision of Cytopathology, Institute of Cytology and Preventive Oncology, I - 7, Sector - 39, Noida, 201301, Uttar Pradesh, India. rm8509@gmail.com.
Bhudev Chandra DasDr. B.R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, 110007, New Delhi, India. bcdas48@hotmail.com.
Alok Chandra BhartiDivision of Molecular Oncology, Institute of Cytology and Preventive Oncology, I - 7, Sector -39, Noida, 201301, Uttar Pradesh, India. alokchandrab@yahoo.com.
Institute of Cytology and Preventive Oncology · INAmbedkar University Delhi · INUniversity College of Medical Sciences · INUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPresent study provides clinical evidence of existence of a functional loop involving miR-21 and let-7a as potential regulators of aberrant STAT3 signaling recently reported by our group in an experimental setup (Shishodia et al. BMC Cancer 2014, 14:996). The study is now extended to a set of cervical tissues that represent natural history of human papillomavirus (HPV)-induced tumorigenic transformation. MATERIALS AND

methodsCervical tissues from histopathologically-confirmed pre-cancer (23) and cancer lesions (56) along with the normal control tissues (23) were examined for their HPV infection status, expression level of miR-21 & let-7a and STAT3 & pSTAT3 (Y705) by PCR-based genotyping, quantitative real-time PCR and immunoblotting.

resultsAnalysis of cancer tissues revealed an elevated miR-21 and reduced let-7a expression that correspond to the level of STAT3 signaling. While miR-21 showed direct association, let-7a expression was inversely related to STAT3 expression and its activation. In contrast, a similar reciprocal expression kinetics was absent in LSIL and HSIL tissues which overexpressed let-7a. miR-21 was found differentially overexpressed in HPV16-positive lesions with a higher oncoprotein E6 level. Overexpression of miR-21 was accompanied by elevated level of other STAT3-regulated gene products MMP-2 and MMP-9. Enhanced miR-21 was found associated with decreased level of STAT3 negative regulator PTEN and negative regulator of MMPs, TIMP-3.

conclusionOverall, our study suggests that the microRNAs, miR-21 and let-7a function as clinically relevant integral components of STAT3 signaling and are responsible for maintaining activated state of STAT3 in HPV-infected cells during cervical carcinogenesis.

Indexed as

BiopsyCarcinogenesisCell Line, TumorCervix UteriFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHuman papillomavirus 16HumansMicroRNAsModels, BiologicalOncogene Proteins, ViralPhosphorylationRepressor ProteinsRNA, MessengerSignal TransductionE6 protein, Human papillomavirus type 16MicroRNAsMIRN21 microRNA, humanmirnlet7 microRNA, humanOncogene Proteins, ViralRepressor ProteinsRNA, MessengerSTAT3 Transcription Factor

Identifiers

PMID26051842
PMCPMC4459448
OpenAlexW2146571198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.